In equity markets, Diageo fizzed to the top of the FTSE 100 after an upgrade to 'buy' from 'sell at UBS, which said it sees upside risks to the US business. Pennon gained after an upgrade to ...
Cardiff Oncology has had a stellar year, with its stock price up a striking +64.86% year-to-date (YTD). This growth outpaces the broader market by a wide margin, especially when compared to the S&P ...